Equator Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 10

Equator Therapeutics General Information

Description

Developer of novel drugs designed to burn calories and improve metabolism. The company is developing drugs that activate the protein that mitochondria naturally use to produce heat, as well as developing a platform to identify compounds that selectively activate this target protein, without side effects, enabling consumers to reduce obesity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4340 Duncan Avenue
  • Suite 210
  • Saint Louis, MO 63110
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 4340 Duncan Avenue
  • Suite 210
  • Saint Louis, MO 63110
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Equator Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC 01-Jan-2024 Completed Startup
8. Early Stage VC 01-Jan-2023 Completed Startup
7. Secondary Transaction - Private 01-Nov-2022 Completed Startup
6. Early Stage VC 01-Jan-2022 Completed Startup
5. Seed Round 01-Dec-2021 Completed Startup
4. Grant 20-Sep-2021 Completed Startup
3. Seed Round 01-Jun-2021 Completed Startup
2. Accelerator/Incubator 18-Mar-2020 $125K $125K Completed Startup
1. Seed Round 01-Mar-2020 Completed Startup
To view Equator Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Equator Therapeutics Patents

Equator Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026060261-A1 Compositions and methods for treating metabolic disorders Pending 13-Sep-2024
AU-2025235503-A1 Compositions and methods for treating metabolic disorders Pending 11-Mar-2024
WO-2025193697-A1 Compositions and methods for treating metabolic disorders Pending 11-Mar-2024 A61K31/433

Equator Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Equator Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioGenerator Ventures Venture Capital Minority
Thoobik Holdings Venture Capital Minority
Healthspan Capital Venture Capital Minority
Endurance28 Venture Capital Minority
Evolution VC Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Equator Therapeutics FAQs

  • When was Equator Therapeutics founded?

    Equator Therapeutics was founded in 2019.

  • Where is Equator Therapeutics headquartered?

    Equator Therapeutics is headquartered in Saint Louis, MO.

  • What is the size of Equator Therapeutics?

    Equator Therapeutics has 6 total employees.

  • What industry is Equator Therapeutics in?

    Equator Therapeutics’s primary industry is Drug Discovery.

  • Is Equator Therapeutics a private or public company?

    Equator Therapeutics is a Private company.

  • What is Equator Therapeutics’s current revenue?

    The current revenue for Equator Therapeutics is .

  • How much funding has Equator Therapeutics raised over time?

    Equator Therapeutics has raised $125K.

  • Who are Equator Therapeutics’s investors?

    BioGenerator Ventures, Thoobik Holdings, Healthspan Capital, Endurance28, and Evolution VC Partners are 5 of 10 investors who have invested in Equator Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process